We expect the revenue to grow at a CAGR of 22% during FY15-FY17E and EBITDAto increase at a CAGR of 128% during FY15-FY17E. Accordingly, we also expectRoCE to expand to 13% and 15% during FY16E and FY17E from 4% in FY15 onthe back of higher execution of orders in hand.